newsfilter
← Latest News
GlobeNewswire·

Kineta to Receive $5 Million Milestone Payment from Merck

KA

SEATTLE, June 29, 2023 (GLOBE NEWSWIRE) -- (June 29, 2023) Kineta, Inc. (NASDAQ:KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune